# Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530

> **NCT00489606** · PHASE1 · COMPLETED · sponsor: **SK Chemicals Co., Ltd.** · enrollment: 16 (actual)

## Conditions studied

- Erectile Dysfunction

## Interventions

- **DRUG:** SK3530

## Key facts

- **NCT ID:** NCT00489606
- **Lead sponsor:** SK Chemicals Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2007-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00489606

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00489606, "Phase I Study to Investigate the Drug Interaction After Oral Administration of Tamsulosin and SK3530". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT00489606. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
